Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
17.03.25
/
50%
€35.20
Target price
17.03.26
€105.64
Performance (%)
-46.02%
Price
08:48
?
This prediction will end soon
Summary
This prediction is currently active. Massive losses of -46.02% have been the result for the BUY prediction by Piper_Sandler. This prediction currently runs until 17.03.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.372% | 4.372% |
| iShares Core DAX® | -1.338% | -5.619% |
| iShares Nasdaq 100 | -1.067% | 2.598% |
| iShares Nikkei 225® | -1.991% | -6.512% |
| iShares S&P 500 | -1.316% | 0.905% |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Piper Sandler from $140.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
13.01.25
13.01.25
€137.24
13.01.26
13.01.26
-50.00%
14.01.26
14.01.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€30.80
25.10.23
25.10.23
€122.98
25.10.24
25.10.24
61.04%
26.10.24
26.10.24